Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer

Cancer Chemotherapy and Pharmacology - Tập 29 Số 6 - Trang 435-438 - 1992
Joseph Aisner1, Margaret Whitacre1, Daniel R. Budman2, K. Propert3, Gary M. Strauss4, David A. Van Echo1, Michael C. Perry5
1University of Maryland Cancer Center UMAB, Baltimore, USA
2North Shore University Hospital, Manhasset, USA
3Cancer and Leukemia Group B, Brookline, USA
4University of Massachusetts - Worcester, USA
5University of Missouri-Columbia, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aisner J, Abrams J (1989) Cisplatin for small cell lung cancer. Semin Oncol 16 (Suppl 6): 2?9

Aisner J, Whitacre MY, Van Echo DA, et al (1982) Combination chemotherapy for small cell carcinoma of the lung: continuous vs alternating non-cross-resistant combinations. Cancer Treat Rep 66: 221?230

Aisner J, Alberti P, Bitran J et al (1983) Role of chemotherapy in small cell lung cancer: a consensus report of the International Association of the Study of Lung Cancer workshop. Cancer Treat Rep 67: 37?43

Aisner J, Whitacre MY, Van Echo DA, et al (1983) Doxorubicin, cyclophosphamide, and etoposide (ACE) by bolus or continuous infusion for small cell carcinoma of the lung (SCCL). Proc Am Assoc Clin Oncol 2: 96

Aisner J, Whitacre MY, Abrams J, et al (1985) Doxorubicin, cyclophosphamide, and etoposide and platinum, doxorubicin, cyclophosphamide, and etoposide for small cell lung cancer. Semin Oncol 13 (Suppl 3): 54?62

Aisner J, Whitacre MY, Budman D, et al (1985) Platinum (P), doxorubicin (A), cyclophosphamide (C), and etoposide (E), PACE for small cell lung cancer (SCLC). Proc Am Soc Clin Oncol 4: 181

Cohen MH, Matthews MJ (1978) Small cell bronchogenic carcinoma: a distinct clinicopathologic entity. Semin Oncol 5: 234?243

Greco FA, Oldham RK (1979) Small cell lung cancer. N Engl J Med 301: 355?358

Janaki LM, McCracken JD, Crowley JJ, et al (1990) Concurrent chemotherapy/radiotherapy for limited small cell carcinoma of lung: a Southwest Oncology Group study. J Clin Oncol 8: 892?898

Johnson DH, DeLeo MJ, Hande KR, et al (1987) High dose induction chemotherapy with cyclophosphamide, etoposide and cisplatin for extensive-stage small cell lung cancer. J Clin Oncol 5: 703?709

Klastersky J, Scullier JP, Dumont JP, et al (1985) Combination chemotherapy with Adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung: a study of the EORTC Lung Cancer Working Party (Belgium). Cancer 56: 71?75

Livingston RB, McKracken JD, Trauth CJ, et al (1982) Isolated pleural effusions in small cell lung carcinoma: favorable prognosis. Chest 81: 208?211

Schabel FM Jr, Trader MW, Laster WR, et al (1979)cis-Dichlorodiammineplatinum(II): Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63: 1459?1473

Scullier JP, Klastersky J, Becquart G et al (1988) Phase II study of an intensive combination chemotherapy with cisplatin, Adriamycin, etoposide, and cyclophosphamide (CAVE) in small cell lung cancer. Eur J Clin Oncol 24: 519?526